Literature DB >> 9851619

Changes and results of surgical strategies for hepatocellular carcinoma: results of a 15-year study on 452 consecutive patients.

T Shuto1, K Hirohashi, S Kubo, H Tanaka, T Tsukamoto, T Yamamoto, T Ikebe, H Kinoshita.   

Abstract

In an attempt to define better surgical strategies for patients with hepatocellular carcinoma (HCC), we conducted a retrospective analysis of 452 patients who underwent hepatic resection at our institute during a period of 15 years. The patients were divided into two groups: group A, comprising 188 patients who underwent hepatic resection before 1988, and group B, comprising 264 patients after 1989. These groups were compared clinicopathologically. The percentage of patients with Child's A disease but without cirrhosis, in group A was lower. The diameter of the resected tumor was larger in group A, and major hepatic resections and curative operations were more frequently performed in group A. In group B, there was less blood loss, the specimen weighed less, and the hospital mortality was lower. Although the tumor-free survival rates were similar between the two groups, the survival rate in group B was significantly better. While even minor hepatic resection accompanied by a lower rate of surgical margin-free surgery has contributed to making hepatic resection safer, it has not improved the tumor-free survival rate. Conversely, recent advances in imaging modalities used during follow-up for the early detection of recurrence and for planning multimodality treatment have contributed to increasing the survival rate.

Entities:  

Mesh:

Year:  1998        PMID: 9851619     DOI: 10.1007/s005950050299

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  12 in total

1.  Hepatocellular Carcinoma in Transplantable Child-Pugh A Cirrhotics: Should Cost Affect Resection vs Transplantation?

Authors:  Theodoros Michelakos; Dimitrios Xourafas; Motaz Qadan; Rafael Pieretti-Vanmarcke; Lei Cai; Madhukar S Patel; Joel T Adler; Fermin Fontan; Usama Basit; Parsia A Vagefi; Nahel Elias; Kenneth K Tanabe; David Berger; Heidi Yeh; James F Markmann; David C Chang; Cristina R Ferrone
Journal:  J Gastrointest Surg       Date:  2018-09-14       Impact factor: 3.452

2.  Preoperative galactose elimination capacity predicts complications and survival after hepatic resection.

Authors:  Claudio A Redaelli; Jean-François Dufour; Markus Wagner; Martin Schilling; Jürg Hüsler; Lukas Krähenbühl; Markus W Büchler; Jürg Reichen
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

3.  The clinical significance of lymph node metastases in patients undergoing surgery for hepatocellular carcinoma.

Authors:  T Uenishi; K Hirohashi; T Shuto; S Kubo; H Tanaka; C Sakata; T Ikebe; H Kinoshita
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

4.  Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma.

Authors:  T Uenishi; K Hirohashi; S Kubo; T Yamamoto; H Hamba; H Tanaka; H Kinoshita
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

5.  Surgical treatment for hepatocellular carcinoma detected after successful interferon therapy.

Authors:  Shoji Kubo; Hiromu Tanaka; Shigekazu Takemura; Satoshi Yamamoto; Seikan Hai; Tsuyoshi Ichikawa; Shintaro Kodai; Hiroji Shinkawa; Taichi Shuto; Kazuhiro Hirohashi
Journal:  Surg Today       Date:  2007-03-26       Impact factor: 2.549

6.  Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan((R))) before curative resection of hepatocellular carcinoma: a pilot study.

Authors:  Seung Up Kim; Sang Hoon Ahn; Jun Yong Park; Do Young Kim; Chae Yoon Chon; Jin Sub Choi; Kyung Sik Kim; Kwang-Hyub Han
Journal:  Hepatol Int       Date:  2008-09-09       Impact factor: 6.047

7.  Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival.

Authors:  Theodoros Michelakos; Filippos Kontos; Yurie Sekigami; Motaz Qadan; Lei Cai; Onofrio Catalano; Vikram Deshpande; Madhukar S Patel; Teppei Yamada; Nahel Elias; Leigh Anne Dageforde; Shoko Kimura; Tatsuo Kawai; Kenneth K Tanabe; James F Markmann; Heidi Yeh; Cristina R Ferrone
Journal:  J Gastrointest Surg       Date:  2020-08-10       Impact factor: 3.452

8.  Adrenal metastasis as first presentation of hepatocellular carcinoma.

Authors:  Kostas Tsalis; Emmanouil Zacharakis; Nikolaos Sapidis; Ioannis Lambrou; Evangelos Zacharakis; Dimitrios Betsis
Journal:  World J Surg Oncol       Date:  2005-07-25       Impact factor: 2.754

9.  Radiotherapy treatment of adrenal gland metastases from hepatocellular carcinoma: clinical features and prognostic factors.

Authors:  Le-Yuan Zhou; Zhao-Chong Zeng; Jia Fan; Bing Chen; Sheng-xiang Rao; Jian He; Ping Yang; Jia-zhou Hou; Zhi-feng Wu; Jian-ying Zhang; Yong Hu
Journal:  BMC Cancer       Date:  2014-11-25       Impact factor: 4.430

10.  Surgical outcome of synchronous second primary cancer in patients with gastric cancer.

Authors:  Tae Kyung Ha; Ji Yeong An; Ho Geun Youn; Jae Hyung Noh; Tae Sung Sohn; Sung Kim
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.